Ciprofloxacin<wbr/>-d<sub>8</sub> (hydro<wbr/>chloride)

Ciprofloxacin-d8 (hydrochloride)

CAT N°: 25466
Price:

From 109.00 92.65

Ciprofloxacin-d8 is intended for use as an internal standard for the quantification of ciprofloxacin (Item No. 14286) by GC- or LC-MS. Ciprofloxacin is a fluoroquinolone antibiotic.{22833} It is active against a variety of Gram-positive and Gram-negative bacteria in vitro, including S. aureus, L. monocytogenes, P. aeruginosa, Legionella, N. gonorrhoeae, and H. pylori (MIC50s = 0.004-1 µg/ml).{32846} It is also active against clinical isolates of Bacteroides, Fusobacterium, Eubacterium, Actinomyces, Peptococcus, Peptostreptococcus, and Streptococcus in vitro (MIC50s = 0.5-2 µg/ml).{32013} Ciprofloxacin inhibits S. aureus DNA gyrase and topoisomerase IV (IC50s = 13.5 and 5.76 µg/ml, respectively).{27493} It reduces mortality in mouse models of intraperitoneal E. coli, P. vulgaris, K. pneumoniae, P. aeruginosa, and S. aureus infection (ED90-100s = 1-5, 2.5-5, 5-10, 20-40, and 80 mg/kg, respectively) and prevents mortality in a mouse model of subcutaneous S. typhimurium infection at 10 mg/kg.{39939,39940} Formulations containing ciprofloxacin have been used in the treatment of bacterial infections.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View